Abstract:1605 Objectives: Immunoglobulin (Ig) heavy chain framework region (FR) of V1 family has been verified to be a major determinant of malignant phenotype of V1 family B-cell lymphoma. The aim of this study was to investigate the possibility of using radioiodine labeled FR antisense oligonucleotides (ASONs) as an imaging agent or antisense therapeutic radiopharmaceutical in lymphoma. Methods: A 18-mer partial phosphorothioate oligonucleotide sequence was synthesized and grafted in 5′with a tyramine group which was further radio iodinated. Radio iodination of the tyramine derivatized oligonucleotides was performed using the chloramine T method.1)Normal CD-1 mice were injected via a tail vein with 148 kBq 125I-FR-ASON (2~3μg). Animals were sacrificed at 1, 2, 4 and 24 h and tissue samples were studied.2)Liposome-mediated 3.33 MBq 131I-FR-ASON(7 ~9 μg)were injected intratumorally tumor-bearing BALB/c mice (6 weeks after inoculation of 107 Namalwa cells) meanwhile liposome-mediated 131I labeled sense oligonucleotides serving as controls. Biodistribution was monitored by sequential scintigraphy and organ radioactivity measurement at 24 h after injection. Percentage of the injected dose per gram (%ID/g) of tumor and tumor/ non-tumor tissue ratios (T/NT) were calculated for each group of mice and the difference between two groups was assessed. Results: The 5′tyramine group allowed specific and stable radio labeling of the ASON with radioiodine. The radioactivity reached its peak at 1 h after injection, and then decreased rapidly in normal mice after intravenous administration of 125I-FR-ASON.The liver, stomach and intestine played an important role in biodistribution and radioactivity counts were low in bone, brain and blood. When 131I-FR-ASON injected intratumorally into mice grafted with Namalwa cell line, images showed tracer accumulate in tumor. Immediately after intratumoral administration, only tumor was visible. Scintiscans performed at 1 and 2 h showed elimination of the tracer from the tumor to the abdomen and at 24 h tumor was clearly seen. %ID/g of tumor and T/NT ratios for the sense group (control) were significantly lower (P Conclusions: Radio labeled Ig FR ASON showed high specificity in V1 family B-cell lymphoma, and it should be considered further for nuclear medicine imaging application and radionuclide antisense therapy.

In Vitro Stability of 188Re-Labeled Morpholino Oligonucleotide and Its Distribution in Mice

^188 Re Labeled MPEG-modified Superparamagnetic Nanogels：preparation and Preliminary Application in Mice

Radiolabeling of MAG3-morpholino Oligomers with 188re at High Labeling Efficiency and Specific Radioactivity for Tumor Pretargeting.

Initial Investigations of 99Mtc-Labeled Morpholinos for Radiopharmaceutical Applications

Preparation of 188Re-Mag3 and in Vivo Evaluation in Mice

A Novel Tetrapeptide for Chelator-Free Radiolabeling in Optimized Preparation of 99Mtc-Radiolabeled Oligonucleotides.

Assessment Of Re-188 Marked Anti Mhc Class Ii Antibody By Peripheral Blood Mononuclear Cells Stimulated By Donor Alloantigen

Preparation and Biodistribution of ~(99M)tc-Pdgfr-β AODN

Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.

One-step synthesis of a radioiodinated anti-microRNA-21 oligonucleotide for theranostics in prostate tumor xenografts

Preparation and Stability Evaluation of Small Interference RNA Radiolabeled with ~(99)Tc~m

Study on Biodistribution and Imaging of Radioiodinated Antisense Oligonucleotides in Nude Mice Bearing Human Lymphoma

In Vitro Research on MicroRNA-155 Targeted Radiolabeled Oligonucleotide in Breast Cancer Cells

Convenient Synthesis and Bioevaluation of New MAG3 Analogs for Rhenium-Labeling of Antibodies IgG

In vitro structure-activity relationship of Re-cyclized octreotide analogues

Predicting the Biodistribution of 99Mtc-Labeled Cmorf Effector in Pretargeted Tumored Mice. Variations in the Dosage of MORF Conjugated Antitumor Antibody

In Vivo Delivery of Antisense Morf Oligomer by Morf/Carrier Streptavidin Nanoparticles

Study on Labeling of Antisense Oligonucleotides of IgH V1 FR mRNA With 125I

Optimized Preparation of a 99m Tc-Radiolabeled Probe for Tracing MicroRNA

Radiolabeling of RGD peptide and preliminary biological evaluation in mice bearing U87MG tumors.

Traumatic pseudoaneurysm of the superficial temporal artery in a child: a case report